Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide - Bengtsson, D; Schrøder, H D; Andersen, M (J Clin Endocrinol Metab, 2015)